Latest News and Press Releases
Want to stay updated on the latest news?
-
Aclarion Strengthens Balance Sheet and Extends Cash Runway Into 2028
-
Aclarion Provides 2025 Update and 2026 Corporate Outlook
-
Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data
-
Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS)
-
Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S.